Equities

Indofarma Tbk PT

INAF:JKT

Indofarma Tbk PT

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (IDR)970.00
  • Today's Change0.00 / 0.00%
  • Shares traded22.30k
  • 1 Year change-58.72%
  • Beta-0.8047
Data delayed at least 10 minutes, as of Dec 06 2022 02:55 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

PT Indofarma Tbk is an Indonesia-based company, which is engaged in the healthcare industry. The Company's business segment based on the products consists of the drug business segment and other medical equipment segment. The medical equipment segment consists of diagnostic and medical equipment. Its business segment based on geographical distribution area covers five regions consisting of Sumatra, Java, Kalimantan, Sulawesi and Bali, West Nusa Tenggara, and East Indonesia. Its products and services include generic drugs, over-the-counter and food, medical devices, non-medical devices and household health products. The Company carries out business activities to produce either alone or under cooperation for finished drug products, such as essential medicines, generic medicines with logos, generic medicines with trade names, traditional medicines, medical equipment, diagnostics, as well as food products, both related to health maintenance and improvement as well as health restoration.

  • Revenue in IDR (TTM)2.31tn
  • Net income in IDR-223.52bn
  • Incorporated1996
  • Employees1.18k
  • Location
    Indofarma Tbk PTJl. Indofarma No. 1, Cikarang BaratBEKASI 17530IndonesiaIDN
  • Phone+62 2 188323971
  • Fax+62 2 188323972
  • Websitehttp://www.indofarma.id
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Phapros Tbk PT1.16tn17.31bn659.40bn1.55k38.090.90339.250.568120.6120.611,381.79869.000.6061.852.00695,446,600.000.8735--1.74--48.72--1.44--0.92631.400.5559--7.23---77.17------
Merck Tbk PT1.15tn163.62bn2.16tn393.0013.222.9811.381.89365.22365.222,561.491,621.141.222.168.412,980,644,000.0017.457.2221.6910.9137.7839.0414.269.531.9234.450.0235426.2262.290.565483.11-3.0711.07-2.69
Darya-Varia Laboratoria Tbk PT1.86tn43.95bn2.73tn1.26k62.171.8825.461.4739.2539.251,657.991,300.030.87192.222.661,498,745,000.002.069.982.7213.5252.3353.532.3710.132.18--0.001867.953.895.54-9.47-0.7147-14.9911.89
Indofarma Tbk PT2.31tn-223.52bn3.05tn1.18k--9.39--1.32-72.15-72.15745.51104.921.116.055.691,842,803,000.00-10.77-1.40-23.64-2.791.3517.81-9.68-1.180.9242-3.140.5993--69.1511.62-136,356.00---18.53--
Tempo Scan Pacific Tbk PT11.98tn818.70bn6.27tn4.55k7.600.91635.490.5233183.00183.002,679.311,516.931.184.349.262,535,298,000.008.488.3311.5111.4634.2637.207.166.441.85--0.160436.322.434.224.578.96-0.12376.96
Kimia Farma Tbk PT10.50tn-180.60bn6.97tn11.51k--0.966926.600.664-32.52-32.521,890.121,297.920.55982.194.54881,718,000.00-1.011.82-1.643.0033.8536.28-1.802.550.59650.54040.549224.7928.5017.211,613.682.4812.1411.14
Soho Global Health Tbk PT6.89tn325.04bn7.04tn2.41k21.672.8317.911.02256.10256.105,431.661,963.831.524.704.872,875,966,000.007.15--12.94--18.72--4.72--1.46--0.0108--14.80--219.67------
Data as of Dec 06 2022. Currency figures normalised to Indofarma Tbk PT's reporting currency: Indonesian Rupiah IDR

Institutional shareholders

0.01%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 31 Jul 2022257.00k0.01%
DFA Australia Ltd.as of 30 Sep 2022576.000.00%
Data from 30 Sep 2022 - 31 Oct 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.